Skip to main content

Displaying 73 - 84 of 569

Jim Dolan Reports a $2.4 Million SPHR Purchase

February 29, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by JANA Partners Management LP.

The investment firm reported a purchase of roughly $11 million in Mercury Systems Inc $MRCY.

CEO Grace Reports a Million-Dollar AMN Purchase

February 28, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Cary Grace, president and CEO of AMN Healthcare Services $AMN.

Grace reported a purchase of almost $1 million in AMN shares.

Pelosi Reports PANW Call Options Purchases

February 27, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The biggest item on today’s list is a filing by Rep. Nancy Pelosi.

The former Speaker of the House bought call options in Palo Alto Networks $PANW worth between $600,000 and $1,250,000.

Executive Chair Hooks Reports an MBUU Buy

February 26, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes via a handful of filings by Michael K. Hooks, executive chair of Malibu Boats Inc $MBUU.

Hooks reported a purchase of $535,250 on his one stock.

CEO Frost Reports Another Million-Share OPK Purchase

February 22, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes via a handful of filings by the CEO and chairman of OPKO Health $OPK, Phillip Frost.

Frost reported a total purchase of 1,000,000 OPK shares, equivalent to $991,700.

ARCH Venture Reports a $20 Million PRME Buy

February 21, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Keith Crandell, the  co-founder and a managing director of ARCH Venture Partners.

ARCH Venture Partners just bought 3,200,000 shares of Prime Medicine Inc $PRME, equivalent to $20 million.

Deerfield Reports a $37 Million LRMR Purchase

February 20, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The largest insider buy on today’s list comes in a Form 4 filing by Deerfield Asset Management’s James Flynn.

The investment firm reported a purchase of $37 million in Larimar Therapeutics $LRMR.